Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
KOREAN SOC GASTROINTESTINAL ENDOSCOPY
Autores
NA, Hee Kyong
Citação
CLINICAL ENDOSCOPY, v.54, n.1, p.25-31, 2021
Resumo
Obesity, along with its comorbidities, has become a significant public health concern worldwide. Bariatric surgery is considered the most effective treatment modality; however, only 2% of patients with obesity undergo bariatric surgery. Endoscopic bariatric and metabolic therapies (EBMTs) are emerging alternatives to traditional bariatric surgery for patients who are not eligible for or do not prefer surgical treatment. EBMTs are generally categorized as space-occupying. gastric restrictive, aspiration, and small bowel therapies. We aimed to review various non-balloon and non-gastroplasty devices with available clinical data and discuss the possible mechanisms of action, efficacy, and safety profile of these EMBTs.
Palavras-chave
Bariatric, Endoscopy, Metabolic, Obesity, Weight loss
Referências
- Abu Dayyeh BK, 2015, GASTROINTEST ENDOSC, V82
- Aithal G, 2019, J HEPATOL, V70, pE70, DOI 10.1016/S0618-8278(19)30124-0
- [Anonymous], 1991, NIH CONSENSUS STATE, V9, P1
- Arterburn DE, 2020, JAMA-J AM MED ASSOC, V324, P879, DOI 10.1001/jama.2020.12567
- Betzel B, 2018, OBES SURG, V28, P3669, DOI 10.1007/s11695-018-3441-3
- Betzel B, 2017, SURG ENDOSC, V31, P2881, DOI 10.1007/s00464-016-5299-6
- Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
- Cherrington Alan D, 2017, Gastrointest Endosc Clin N Am, V27, P299, DOI 10.1016/j.giec.2016.12.002
- Cho JH, 2021, CLIN ENDOSC, V54, P9, DOI 10.5946/ce.2020.302
- Gersin KS, 2010, GASTROINTEST ENDOSC, V71, P976, DOI 10.1016/j.gie.2009.11.051
- Ginsberg GG, 2011, GASTROINTEST ENDOSC, V74, P943, DOI 10.1016/j.gie.2011.08.053
- Glaysher MA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018598
- de Moura DTH, 2019, WORLD J GASTRO ENDOS, V11, P322, DOI 10.4253/wjge.v11.i5.322
- de Moura EGH, 2015, OBES SURG, V25, P1618, DOI 10.1007/s11695-015-1594-x
- Jirapinyo P, 2020, CLIN ENDOSC, V53, P686, DOI 10.5946/ce.2019.181
- Jirapinyo P, 2018, DIABETES CARE, V41, P1106, DOI 10.2337/dc17-1985
- Koehestanie P, 2014, ANN SURG, V260, P984, DOI 10.1097/SLA.0000000000000794
- Machytka E, 2017, GASTROINTEST ENDOSC, V86, P904, DOI 10.1016/j.gie.2017.07.009
- Nystrom M, 2018, OBES SURG, V28, P1860, DOI 10.1007/s11695-017-3096-5
- Quezada N, 2018, SURG ENDOSC, V32, P260, DOI 10.1007/s00464-017-5672-0
- Rajagopalan H, 2016, DIABETES CARE, V39, P2254, DOI 10.2337/dc16-0383
- Rodriguez L, 2009, DIABETES TECHNOL THE, V11, P725, DOI 10.1089/dia.2009.0063
- Roehlen N, 2020, OBES SURG, V30, P1200, DOI 10.1007/s11695-019-04324-2
- Rohde U, 2016, DIABETES OBES METAB, V18, P300, DOI 10.1111/dom.12603
- Ruban A, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/7823182
- Ryou M, 2016, SURG ENDOSC, V30, P4533, DOI 10.1007/s00464-016-4789-x
- Sandler BJ, 2015, SURG ENDOSC, V29, P3298, DOI 10.1007/s00464-015-4081-5
- Sandler BJ, 2011, SURG ENDOSC, V25, P3028, DOI 10.1007/s00464-011-1665-6
- Schouten R, 2010, ANN SURG, V251, P236, DOI 10.1097/SLA.0b013e3181bdfbff
- Sullivan S, 2017, GASTROENTEROLOGY, V152, P1791, DOI 10.1053/j.gastro.2017.01.044
- Sullivan S, 2013, GASTROENTEROLOGY, V145, P1245, DOI 10.1053/j.gastro.2013.08.056
- Swei EC, 2020, TECH VASC INTERV RAD, V23, DOI 10.1016/j.tvir.2020.100659
- Tarnoff M, 2009, SURG ENDOSC, V23, P650, DOI 10.1007/s00464-008-0125-4
- Thompson CC, 2017, AM J GASTROENTEROL, V112, P447, DOI 10.1038/ajg.2016.500
- US Food and Drug Administration, 2016, SUMM SAF EFF DAT SSE
- van Baar ACG, 2020, GUT, V69, P295, DOI 10.1136/gutjnl-2019-318349
- van Rijn S, 2019, OBES SURG, V29, P1117, DOI 10.1007/s11695-018-03659-6
- Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
- Yoon JY, 2021, CLIN ENDOSC, V54, P17, DOI 10.5946/ce.2021.019